These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 954821)

  • 1. Tolerance to hexobarbital and supersensitivity to pilocarpine after chronic barbital treatments in the rat.
    Wahlstrŏm G; Ekwall T
    Eur J Pharmacol; 1976 Jul; 38(1):123-9. PubMed ID: 954821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some aspects of the changes induced by chronic barbital treatments in the male rat.
    Wahlström G
    Drug Alcohol Depend; 1979; 4(3-4):221-33. PubMed ID: 575087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atropine in the abstinence after chronic barbital treatment in the rat.
    Wahlström G
    Pharmacol Biochem Behav; 1980; 13 Suppl 1():249-55. PubMed ID: 7195576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between pilocarpine and hexobarbital in male rats.
    Wahlström G
    Psychopharmacology (Berl); 1976 Sep; 49(2):159-66. PubMed ID: 825902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatments in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1976 Aug; 48(3):239-45. PubMed ID: 823578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barbital alteration of central nervous system sensitivity to hexobarbital in the rat.
    Schnell RC; Stoll RE; Prosser TD
    Psychopharmacology (Berl); 1976 May; 47(1):93-6. PubMed ID: 959468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on acute tolerance to ethanol in the abstinence period after long-term barbital treatment in the rat.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):152-60. PubMed ID: 573957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between atropine and the steric isomers of hexobarbital in normal rats and rats made tolerant to barbital.
    Wahlström G
    Eur J Pharmacol; 1979 Nov; 59(3-4):219-25. PubMed ID: 527647
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between spontaneous and electrically induced convulsions and their short- and long-term effects in the abstinence after chronic barbital treatment in the rat.
    Wahlström G
    Brain Res; 1983 May; 266(2):225-32. PubMed ID: 6871660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of brain sensitivity to the convulsive effects of choline and changes induced by chronic barbital treatments in the rat.
    Wahlström G
    Eur J Pharmacol; 1978 Oct; 51(3):219-27. PubMed ID: 710501
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction between spontaneous convulsions and tolerance to hexobarbital in the abstinence after chronic barbital treatments in the rat.
    Wahlström G
    Life Sci; 1976 Dec; 19(12):1817-26. PubMed ID: 1034185
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity pattern and convulsions in the abstinence period after barbital treatment in the rat.
    Wahlström G; Larsson R
    Pharmacol Biochem Behav; 1977 Feb; 6(2):187-92. PubMed ID: 558618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of hydralazine with barbiturates.
    Czyzewska-Szafran H; Wutkiewicz M
    Pol J Pharmacol Pharm; 1977; 29(4):347-57. PubMed ID: 905202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to ethanol and cross-tolerance to pentobarbital and barbital.
    Gougos A; Khanna JM; Lê AD; Kalant H
    Pharmacol Biochem Behav; 1986 Apr; 24(4):801-7. PubMed ID: 3714775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cholinergic function in rat brain late in abstinence after chronic barbital treatment.
    Nordberg A; Wahlström G
    Drug Alcohol Depend; 1981 Feb; 7(1):51-61. PubMed ID: 7215155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potencies of barbiturates in mice selectively bred for resistance or susceptibility to nitrous oxide anesthesia.
    Koblin DD; Lurz FW; O'Connor B; Nelson NT; Eger EI; Bainton CR
    Anesth Analg; 1984 Jan; 63(1):35-9. PubMed ID: 6691562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated withdrawal from barbital as a drive for 'drug taking behavior' in rats.
    Jänicke UA; Coper H
    Drug Alcohol Depend; 1984 Jan; 13(1):43-54. PubMed ID: 6539666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of cocaine with barbital, pentobarbital and ethanol.
    Misra AL; Pontani RB; Vadlamani NL
    Arch Int Pharmacodyn Ther; 1989; 299():44-54. PubMed ID: 2774771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.